Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour vs 24-hour Postpartum Magnesium Sulfate for Severe Preeclampsia
NCT04576364Completed
- Sponsor
- Assiut University
- Start
- Nov 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of magnesium sulfate in preeclampsia (2 arms), sponsored by Assiut University. Primary endpoint: Need to prolong treatment at 12 hours. Started Nov 2020; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04576364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04576364.